HCG (Human Chorionic Gonadotropin) vs Octreotide
Overview
HCG (Human Chorionic Gonadotropin) and Octreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares HCG (Human Chorionic Gonadotropin) and Octreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| HCG (Human Chorionic Gonadotropin) | Octreotide | |
|---|---|---|
| Category | Hormonal | Hormonal |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 250-500 IU | 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) |
| Frequency | multiple weekly | Every 4 weeks (LAR); two to four times daily (immediate-release) |
| Reported benefits | Testosterone support, fertility, testicular health | Reduction of growth hormone and IGF-1 in acromegaly, suppression of carcinoid flushing and diarrhea, control of VIPoma-associated watery diarrhea, antiproliferative effect on low-grade neuroendocrine tumors, reduction of urinary 5-HIAA biomarkers |
| Reported side effects | Possible estrogen increase, injection site reactions | Gallstones and biliary sludge, diarrhea, nausea, abdominal discomfort, sinus bradycardia, hyperglycemia, hypoglycemia, hypothyroidism, steatorrhea, injection-site pain |
Key differences
Primary use. HCG (Human Chorionic Gonadotropin) is categorised under Hormonal, while Octreotide falls under Hormonal. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. HCG (Human Chorionic Gonadotropin): not FDA-approved; treated as a research compound. Octreotide: FDA-approved.
Dosing. HCG (Human Chorionic Gonadotropin) is typically dosed at 250-500 IU (multiple weekly). Octreotide is typically dosed at 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) (Every 4 weeks (LAR); two to four times daily (immediate-release)).
Can you stack them?
Some protocols combine peptides, but stacking HCG (Human Chorionic Gonadotropin) and Octreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between HCG (Human Chorionic Gonadotropin) and Octreotide?
- HCG (Human Chorionic Gonadotropin) and Octreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status. HCG (Human Chorionic Gonadotropin) is not FDA-approved; generally classified as a research compound, whereas Octreotide is FDA-approved for one or more indications.
- What is HCG (Human Chorionic Gonadotropin) used for?
- Testosterone production support.
- What is Octreotide used for?
- FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988.
- Can you take HCG (Human Chorionic Gonadotropin) and Octreotide together?
- Some users combine peptides within a single protocol, but stacking HCG (Human Chorionic Gonadotropin) and Octreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is HCG (Human Chorionic Gonadotropin) or Octreotide FDA-approved?
- HCG (Human Chorionic Gonadotropin) is not FDA-approved; generally classified as a research compound. Octreotide is FDA-approved for one or more indications.
Read the full articles
- HCG (Human Chorionic Gonadotropin) — full monograph: mechanism, research, dosing & references
- Octreotide — full monograph: mechanism, research, dosing & references